Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Eptifibatide Therapy Following Intravenous Thrombolysis in Acute Ischemic Stroke Patients Within 4.5 to 24 Hours After Onset: A Multicenter, Randomized Controlled Trial

NCT07347626 is registered in ClinicalTrials.gov with Xinqiao Hospital of Chongqing as lead sponsor.

NCT NCT07347626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07347626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Eptifibatide Therapy Following Intravenous Thrombolysis in Acute Ischemic Stroke Patients Within 4.5 to 24 Hours After Onset: A Multicenter, Randomized Controlled Trial
Lead sponsor
Xinqiao Hospital of Chongqing
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
December 31, 2029
Enrollment
786 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke